Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
June 4, 2019 Off

2019 Ion Channel Modulators Report – Global Market Analysis, Trends, and Forecasts, 2015-2018 & 2019-2022 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Ion Channel Modulators: Global Market Analysis, Trends, and Forecasts” report has been added to ResearchAndMarkets.com’s offering. This report…

June 4, 2019 Off

ARS Pharmaceuticals Announces Results from EPI-04 Clinical Study of ARS-1 Intranasal Epinephrine Spray in Allergy Patients with Allergic Rhinitis

By BusinessWire

Results demonstrate rapid epinephrine absorption with an overall pharmacokinetic profile comparable to epinephrine injection in allergy-induced patients SAN DIEGO–(BUSINESS WIRE)–ARS…

June 4, 2019 Off

Dance Biopharm to Present Data from Phase 2 Clinical Trial of Dance 501 Inhaled Insulin Therapy at American Diabetes Association Meeting

By BusinessWire

– This trial, conducted in patients with type 2 diabetes, compared three doses each of Dance 501 inhaled insulin and…

June 4, 2019 Off

Upcoming Pharm-Olam Webinar Helps Sponsors Manage Rescue Study Transitions

By BusinessWire

HOUSTON–(BUSINESS WIRE)–Pharm-Olam, a global, midsized CRO offering full-service clinical development solutions for oncology-hematology, infectious diseases and vaccines and rare diseases,…

June 4, 2019 Off

Janssen Seeks to Expand Use of ERLEADA® (apalutamide) in the Treatment of Patients with Metastatic Hormone-Sensitive Prostate Cancer

By BusinessWire

Application supported by data from the Phase 3 TITAN study which were recently presented at the 2019 ASCO Annual Meeting…

June 4, 2019 Off

IQVIA’s OCE Technology Platform Selected by Zambon to Establish a Global Multichannel Commercial Engagement Model for OTC Business

By BusinessWire

Italian multinational pharmaceutical company to coordinate all physical and digital activities with pharmacists using IQVIA Technologies’ end-to-end solution. DANBURY, Conn.…

June 4, 2019 Off

Asuragen NGS System Streamlines Detection of NSCLC-associated DNA Mutations, Gene Fusions, and RNA Expression Targets in Single Workflow

By BusinessWire

The targeted NGS panel enables the detection of 135 RNA and 55 DNA variants associated with non-small cell lung cancer…

June 4, 2019 Off

Agilent Survey of Pharma Lab Leaders Uncovers Challenges in Workflow and Laboratory Efficiencies

By BusinessWire

SANTA CLARA, Calif.–(BUSINESS WIRE)–Agilent Technologies Inc. (NYSE: A) announced today the results of its first Pharma Lab Leaders Survey looking…

June 4, 2019 Off

Vertex to Present Data at ECFS Conference on Potential Impact of Early Treatment and Long-Term Treatment with CFTR Modulators on the Underlying Cause of CF

By BusinessWire

BOSTON–(BUSINESS WIRE)–#cf—Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that data from six scientific abstracts from the company’s portfolio of cystic…

June 4, 2019 Off

Newomics Announces a Co-Marketing Agreement to Improve Performance of High-throughput Workflows

By BusinessWire

BERKELEY, Calif.–(BUSINESS WIRE)–Newomics Inc., a commercial-stage biotechnology company that sells and develops mass spectrometry products, services and diagnostics, today announced…

Posts pagination

Previous 1 … 5,738 5,739 5,740 … 6,212 Next

Popular posts

Medicago, GSK report primary and secondary endpoints with available data met in trial dominated by COVID-19 variants

December 10, 2021 Off

Aptar’s Bidose Nasal System Delivers CARDAMYST™ (etripamil), the First and Only Self-Administered FDA-Approved Nasal Spray for Paroxysmal Supraventricular Tachycardia (PSVT)

December 18, 2025 Off
Cosentyx meets the primary endpoints

Cosentyx meets the primary endpoints

June 15, 2015 Off
Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

June 15, 2015 Off
Strensiq in HPP patiens therapy get approval from European Commission

Strensiq in HPP patiens therapy get approval from European Commission

September 13, 2015 Off

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine